"AstraZeneca COVID 19 Vaccine"
Latest news and video coverage curated from trusted media outlets
| 0 shares | ShareTweetSavePostSend |
You Might Like
Indian Lawyer Gets Prestigious "Freedom of the City of London" AwardAn India born prolific lawyer, Ajit Mishra, has been conferred with "*Freedom of the City of London Award*" at Guildhall today for his outstanding contribution in legal and public life. Mr Mishra is..NewsVoir - Published | |
Canada set to 'throw out' 13.6 million doses of Oxford-AstraZeneca Covid-19 vaccine, here's whyCanada signed a contract with AstraZeneca in 2020 to get 20 million doses of its vaccine, and 2.3 million Canadians received at least one dose of it.DNA - Published | |
Serum Institute has applied for full market authorisation of Covishield: CEO Adar PoonawalaSerum Institute has applied to the Indian health ministry and Central Drugs Standard Control Organisation (CDSCO) for full market authorisation for its Covishield vaccine, company's CEO Adar Poonawalla..IndiaTimes - Published | |
Lancet study about Covishield 3 months efficacy misquoted, say expertsThe Lancet study reportedly stated that the protection offered by the Oxford AstraZeneca COVID-19 vaccine Covishield declines after 3 months.Zee News - Published | |
Good news for Indian travellers! UK to add Covaxin to approved list from November 22The move follows the World Health Organisation's (WHO) Emergency Use Listing for Covaxin, which is the second most used formulation in India. Covishield, the India-manufactured Oxford-AstraZeneca..Zee News - Published | |
Oxford AstraZeneca COVID-19 vaccine can set off this nerve disorder, says European Medicines AgencyThe nerve disorder as a possible side-effect of AstraZeneca vaccine is categorized in the lowest occurrence category of side-effects, as "very rare."DNA - Published | |
Sarah Gilbert, lead scientist behind Oxford-AstraZeneca COVID-19 vaccine, gets standing ovation at Wimbledon -- WatchThe Wimbledon spectators also applauded the efforts of organisations that have contributed to Britain's fight against COVID-19.Zee News - Published | |
Covishield not a ‘green pass’, Europe-bound Indians fretBENGALURU: The exclusion of Covishield, AstraZeneca’s Covid-19 vaccine manufactured by Pune-based Serum Institute of India, from the European Union’s Covid ‘Green Pass’ has left hundreds of..IndiaTimes - Published | |
Two shots of AstraZeneca provide 85-90% efficacy against COVID-19, suggests UK dataPublic Health England (PHE) said that the two doses of the Oxford/AstraZeneca COVID-19 vaccine may provide around 85% to 90% effectiveness against COVID-19 disease.Zee News - Published | |
Two AstraZeneca Covid shots 85-90% effective: UK real-world analysisTwo doses of the Oxford/AstraZeneca Covid-19 vaccine are around 85% to 90% effective against symptomatic disease, Public Health England (PHE) said on Thursday, citing an analysis of real-world data..IndiaTimes - Published | |
European Union doesn't renew order for AstraZeneca vaccineThe EU Commission did not renew its order for AstraZeneca's COVID-19 vaccine, the European Union's Internal Market Commissioner said Sunday.Zee News - Published | |
Study finds slightly increased blood clot rates after AstraZaneca COVID-19 shotA large study in Denmark and Norway has found slightly increased rates of vein blood clots, including in the brain, among adults who had received their first dose of the Oxford-AstraZeneca COVID-19..Zee News - Published | |
Powerful Indians making aggressive calls for COVID vaccines: Serum CEO Adar PoonawallaThe Serum Institute chief spoke about receiving aggressive calls from some of the most powerful people in India, demanding supplies of Covishield -- the Oxford/AstraZeneca COVID-19 vaccine that the..Zee News - Published | Serum Institute plans to start Covid vaccine production outside India: ReportThe Serum Institute of India, which manufactures the AstraZeneca Covid-19 vaccine, is planning to start vaccine production in other countries as it struggles to meet supply commitments, its chief..IndiaTimes - Published |
